Alexion Pharmaceuticals I... (ALXN)
182.50
0.00 (0.00%)
At close: Jan 01, 1970, 12:00 AM
0.00% (1D)
| Bid | n/a |
| Market Cap | 0 |
| Revenue (ttm) | 6.26B |
| Net Income (ttm) | 681.8M |
| EPS (ttm) | 3.081 |
| PE Ratio (ttm) | 59.23401493021746 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | n/a |
| Volume | 3 |
| Avg. Volume (20D) | 4,222,993 |
| Open | 181.04 |
| Previous Close | 182.50 |
| Day's Range | 180.21 - 182.67 |
| 52-Week Range | 99.91 - 187.45 |
| Beta | 1.26 |
About ALXN
Alexion Pharmaceuticals, Inc. develops and commercializes various therapeutic products. The company offers ULTOMIRIS (ALXN1210/ravulizumab-cwvz), a C5 inhibitor for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS); and SOLIRIS (eculizumab), a monoclonal antibody for the treatment of PNH, aHUS, generalized myasthenia gravis (gMG), and neuromyelitis optica spectrum disorder (NMOSD). It also pr...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 1, 1996
Employees 3,837
Stock Exchange NASDAQ
Ticker Symbol ALXN
Website http://www.alexion.com